Results 71 to 80 of about 10,588 (94)

Prognostic significance of polyvascular disease in heart failure with preserved left ventricular ejection fraction

, 2019
Koichiro Fujisue, Takanori Tokitsu, Eiichiro Yamamoto, Daisuke Sueta, Masafumi Takae, Taiki Nishihara, Fumi Oike, Hiroki Usuku, Miwa Ito, Kota Motozato, Hisanori Kanazawa, Satoshi Araki, Yuichiro Arima, Seiji Takashio, Yasuhiro Izumiya, Satoru Suzuki, Kenji Sakamoto, Koichi Kaikita, Kenichi Tsujita   +18 more
openalex   +1 more source

Atrial Fibrillation in Heart Failure Patients with Preserved or Reduced Ejection Fraction. Prognostic significance of Rhythm control strategy with Catheter Ablation

, 2019
Nicolás Vecchio
openalex   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Heart Failure With Preserved Ejection Fraction

JAMA, 2023
ImportanceHeart failure with preserved ejection fraction (HFpEF), defined as HF with an EF of 50% or higher at diagnosis, affects approximately 3 million people in the US and up to 32 million people worldwide. Patients with HFpEF are hospitalized approximately 1.4 times per year and have an annual mortality rate of approximately 15%.ObservationsRisk ...
Margaret M, Redfield, Barry A, Borlaug
  +5 more sources

Dapagliflozin in Heart Failure with Preserved Ejection Fraction

New England Journal of Medicine, 2023
To the Editor: Solomon et al. (Sept. 22 issue)(1) report on the Dapagliflozin Evaluation to Improve the Lives of Patients with Preserved Ejection Fraction Heart Failure (DELIVER) trial, which showed reduced risks of heart failure-related outcomes (hospitalization for heart failure or an urgent visit for heart failure) among patients with a mildly ...
Domenico Gabrielli, Fabrizio Oliva, Giuseppe Zuccala   +2 more
openaire   +6 more sources

Heart failure with preserved ejection fraction

Nature Reviews Disease Primers
Heart failure with preserved ejection fraction (HFpEF) accounts for nearly half of all heart failure cases and has a prevalence that is expected to rise with the growing ageing population. HFpEF is associated with significant morbidity and mortality.
Carine E. Hamo, Colette DeJong, Nick Hartshorne-Evans, Lars H. Lund, Sanjiv J. Shah, Scott Solomon, Carolyn S. P. Lam   +6 more
  +5 more sources

Heart failure with preserved ejection fraction (diastolic heart failure)

Orvosi Hetilap, 2012
Diastolic heart failure, which is also called as heart failure with preserved ejection fraction, is a clinical syndrome in which patients have signs and symptoms of heart failure, normal or near normal left ventricular ejection fraction (≥50%) and evidence of diastolic dysfunction.
István, Czuriga, Attila, Borbély, Dániel, Czuriga, Zoltán, Papp, István, Edes   +4 more
openaire   +2 more sources

Diagnosing heart failure with preserved ejection fraction

Expert Opinion on Medical Diagnostics, 2013
Heart failure with preserved ejection fraction (HFPEF) is a common syndrome, accounting for about 50% of all patients with heart failure (HF). Morbidity and mortality are similar to patients with HF with reduced ejection fraction (HFREF), yet no effective treatment has been identified in randomized clinical trials.This article provides an overview of ...
Becher, Peter Moritz, Lindner, Diana, Fluschnik, Nina, Blankenberg, Stefan, Westermann, D.   +4 more
openaire   +3 more sources

Heart Failure: Heart Failure With Preserved Ejection Fraction.

FP essentials, 2021
The incidence and prevalence of heart failure (HF) in the United States are high, with an estimated 6.2 million cases, and these numbers are expected to increase. Age is a nonmodifiable risk factor for HF development. Hypertension, diabetes, and ischemic heart disease are modifiable risk factors that can be addressed to reduce the morbidity and ...
openaire   +1 more source

Heart Failure with Preserved Ejection Fraction

Cardiology Clinics, 2022
Nicolas Isaza, Pablo A. Quintero
openaire   +2 more sources

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Ca-A Cancer Journal for Clinicians, 2021
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel   +2 more
exaly